Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avidity Biosciences (RNA) Income towards Parent Company: 2019-2025

Historic Income towards Parent Company for Avidity Biosciences (RNA) over the last 7 years, with Sep 2025 value amounting to -$174.1 million.

  • Avidity Biosciences' Income towards Parent Company fell 117.13% to -$174.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$548.5 million, marking a year-over-year decrease of 95.95%. This contributed to the annual value of -$322.1 million for FY2024, which is 52.18% down from last year.
  • Latest data reveals that Avidity Biosciences reported Income towards Parent Company of -$174.1 million as of Q3 2025, which was down 11.11% from -$156.7 million recorded in Q2 2025.
  • In the past 5 years, Avidity Biosciences' Income towards Parent Company ranged from a high of -$23.8 million in Q1 2021 and a low of -$174.1 million during Q3 2025.
  • For the 3-year period, Avidity Biosciences' Income towards Parent Company averaged around -$89.1 million, with its median value being -$70.7 million (2024).
  • Data for Avidity Biosciences' Income towards Parent Company shows a maximum YoY slumped of 291.80% (in 2021) over the last 5 years.
  • Avidity Biosciences' Income towards Parent Company (Quarterly) stood at -$38.5 million in 2021, then slumped by 31.07% to -$50.5 million in 2022, then fell by 19.59% to -$60.3 million in 2023, then slumped by 69.81% to -$102.5 million in 2024, then crashed by 117.13% to -$174.1 million in 2025.
  • Its last three reported values are -$174.1 million in Q3 2025, -$156.7 million for Q2 2025, and -$115.3 million during Q1 2025.